The Federal Government has committed $346 million in co-financing for HIV, tuberculosis, and malaria programs in 2026 to strengthen Nigeria’s healthcare system.

Coordinating Minister of Health, Muhammad Ali Pate, announced the funding at the launch of Lenacapavir, a long-acting injectable for HIV prevention, in Abuja.

The funds, approved by President Bola Tinubu, will cover medical commodities, lab surveillance, reagents, primary healthcare expansion, and financial protection for citizens.

Minister of State for Health, Iziaq Salako, revealed that 93% of people living with HIV know their status, 99% are on treatment, and 95% have achieved viral suppression.

Lenacapavir, administered twice yearly, offers a convenient alternative to daily HIV pills, with rollout already in states including Anambra, Ebonyi, Gombe, Kwara, Akwa Ibom, Cross River, Benue, and the FCT.

Pregnant women are not yet eligible due to limited safety data, but the drug represents a major breakthrough in expanding HIV prevention options across Nigeria.